2015 American Transplant Congress Archives

T Cell C5a Receptor (C5aR) Signaling Regulates T Follicular Helper Cell (Tfh) Induction

D. Verghese, P. Heeger.
T Cell Receptor Repertoire Analysis of BKV-Specific T Cells in Peripheral Blood Samples By Next Generation Sequencing Reveals Differential Role and Kinetics of CD4 and CD8 T Cell Clones in Viral Control

M. Nienen,¹ W. Benjamin,¹ L. Kuchenbecker,^1,2,3 J. Hecht,¹ P. Reinke,^1,4 A. Neumann,¹ N. Babel.^1,4
T Cell Specific Up Regulation of Nrf2 Regulated Antioxidant Response Protects from Kidney Ischemia Reperfusion Injury in Mice

S. Noel,¹ M. Martina,² S. Bandapalle,¹ S. Reddy,³ L. Racusen,² A. Hamad,² H. Rabb.¹
T Cell Transfer With iNKT Cell Activation Facilitate Engraftment of Bone Marrow Cells Without GvHD

R. Ishii,¹ T. Hirai,¹ S. Miyairi,¹ M. Ikemiyagi,¹ K. Omoto,¹ Y. Ishii,² K. Tanabe.¹
T-bet Directs nTreg Homing Into Draining Lymph Nodes by Regulation of Specific Migration and Adhesion Receptors

Y. Xiong, S. Ahmad, D. Iwami, C. Brinkman, J. Bromberg.
T-Cell Depletion Versus Interleukin-2 Antagonists in a Kidney Transplant Model of Sensitized Rhesus Macaques

C. Burghuber,^1,2 J. Kwun,¹ E. Page,¹ F. Leopardi,³ A. Gibby,¹ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.¹
T-Cell Immune Function Vs. Gene Expression Profiling for Heart Transplant Rejection

M. Luu, M. Kittleson, J. Patel, F. Liou, S. Siddiqui, L. Piponniau, A. Hage, D. Chang, L. Czer, A. Trento, J. Kobashigawa.
T-Cell Mediated Vascular Rejection Can Be Identified By the Combined Measurement of Five Specific microRNAs in Blood

M. Matz,¹ K. Fabritius,¹ C. Lorkowski,¹ M. Dürr,¹ J. Gaedeke,¹ P. Durek,² J. Grün,² A. Goestemeyer,¹ F. Bachmann,¹ K. Wu,¹ B. Rudolph,¹ U. Weber,¹ C. Haftmann,² N. Unterwalder,³ N. Lachmann,¹ A. Radbruch,² H.-H. Neumayer,¹ M.-F. Mashreghi,² K. Budde.¹
Tacrolimus for the Treatment of Refractory Biopsy-Proven Acute Cellular Rejection in Patients on Belatacept-Based, CNI- and Steroid-Free Immunosuppression Regimens

K. Trobaugh,¹ A. Shields,^1,2 S. Tremblay,¹ R. Alloway,¹ M. Cardi,² D. Witte,¹ F. Paterno,¹ M. Cuffy,¹ E. Woodle.¹
Tacrolimus Trough Concentrations Increase in Intestinal Transplant Recipients During Episodes of Acute Cellular Rejection

A. Lichvar,¹ D. Deen,² H. Johnson,¹ J. Bonner,³ G. Bond,⁴ G. Costa,⁴ R. Cruz,⁴ K. Abu-Elmagd,⁵ R. Venkataramanan.^6,7
Tandem P-Selectin Glycoprotein Ligand-Immunoglobulin (TSGL-Ig) Protects Liver Endothelial Cells Against Prolonged Cold Preservation Injury in Mouse Liver Transplantation

C. Zhang,¹ H. Ji,¹ Y. Liu,¹ X. Shen,¹ F. Gao,¹ R. Busuttil,¹ G. Shaw,² J. Kupiec-Weglinski.¹
Targeted Rapamycin Nanotherapy Dampens Memory T Cell Function

S. Nadig,¹ S. Esckilsen,¹ A.-M. Broome,² S. Dixit,² C. Atkinson.³
Targeted Silencing of TLR Adaptor Genes Using Mannose Liposome to Prolong Cardiac Allograft Survival

X. Zhang,¹ J. Jiang,² X. Zheng,¹ J. Shi,³ T. Zwiep,¹ N. Johnston,¹ D. Quan,^1,2 W.-P. Min.^1,2,3
Targeting Complement Pathways During Ischemia and Reperfusion: Implications for the Prevention of Delayed Graft Function

Z. Yu,¹ S. Qi,² M. Lasaro,¹ K. Bouchard,¹ C. Dow,¹ K. Moore,¹ Z. Wu,² A. Barama,² J. Xu,² K. Johnson,¹ A. Marozsan,¹ Y. Wang.¹
Targeting Leukocyte Integrin CD11b/CD18 With a Novel mAb Salvages Renal Function Following an Otherwise Irreversible Ischemic Insult in Cynomolgus Monkeys

A. Cosimi,¹ A. Dehnadi,¹ R. Smith,² D. Ko,¹ X. Li,³ M. Arnaout.³
Technical Aspects of Reconstruction of Middle Hepatic Vein and Multiple Inferior Right Hepatic Veins Using Dual Artificial Vascular Grafts in Right Lobe Living Donor Liver Transplantation: “V-Plasty” Technique for Common Outflow Reconstruction Vs Second IVC Anastomosis

P.-C. Li, L. Jeng, A. Thorat, H.-R. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.
Temporal Increase in the Incidence of Post-Transplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients: Analysis of 2 US Insurance Administrative Claims Databases

T. Kou, H.-U. Meier-Kriesche, J. Preston, A. Gomez.
Ten-Year Follow-Up After Live Kidney Donation – A Prospective Cohort Study

S. Janki,¹ K. Klop,¹ I. Dooper,² W. Weimar,³ J. IJzermans,¹ N. Kok.¹
TGFβ Production By B Cells Is Critical for Transplant Tolerance Induction

J. Kim,¹ W. Liu,^1,2 L. Liu,^1,2 K. Lee,¹ R. Stott,¹ H. Yeh,¹ J. Markmann.¹
TGR5 Regulates Innate Immune Responses in Mouse Liver Ischemia-Reperfusion Injury Through NRF2/HO-1 Signaling Pathway

J. Rao, B. Hao, X. Wang, F. Zhang, L. Lu.
Th-17 Alloimune Responses in Renal Allograft Biopsies from Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T-Cell Mediated Rejection

M. Matignon,^1,2 A. Aissat,³ F. Canoui-Poitrine,⁴ C. Grondin,² D. Desvaux,⁵ D. Saadoun,⁶ P. Lang,^1,2 J. Cohen,² P. Grimbert.^1,2
Th17 Mediates Inflammatory Responses After Lung Transplantation

J. Xu,¹ L. Wang,¹ Q. Chen,² S. Xia,¹ X. Li,¹ H. Li,² Y. Ding.^1,3
Th17-Mediated Alloimmune Responses Play a Key Role in Intestinal Allograft Rejection in Humans

A. Kroemer, S. Wanta, J. Diaz, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein.
The 20S Proteasome Is Active in Apoptotic Nanovesicles and Controls Anti-LG3 Antibody Production

M. Dieudé,^1,4 C. Bell,^2,4 J. Turgeon,^1,4 D. Beillevaire,^1,4 K. Hamelin,^1,4 S. Qi,^1,4 N. Pallet,^1,4 C. Rondeau,³ D. Gingras,³ M. Desjardins,³ P. Thibault,^2,4 M.-J. Hébert.^1,4
The Association Between Donor & Recipient Gene Variants and Tacrolimus Safety & Efficacy in a Diverse Cohort of Kidney Transplant Recipients

D. Taber, T. Srinivas, N. Pilch, M. Gebregziabher, L. Egede, P. Baliga, K. Chavin.
The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function

D. Felix,¹ B. Astor,² D. Hager,¹ A. Djamali.²
The Association of Systemic Indoleamine 2,3 Dioxygenase (IDO) Activity Simultaneous With Chronic Rejection On Allograft Kidney Biopsy

V. Dharnidharka, L. Hesemann, J. Mitsios, H. O'Gorman, M. Gunasekaran, D. Dietzen, T. Mohanakumar.
The Benefit of Hepatitis C Donor Kidney Transplantation Is Limited to Hepatitis C Positive Patients Over 50 Years of Age

T. Myint, A. Wright, C. Rose, C. Kennedy, J. Dong, J. Gill, J. Gill.
The Best Regimen With Rituximab for ABO-Incompatible Living Donor Liver Transplantation

H. Egawa,¹ K. Umeshita,² S. Uemoto.³
The Burden of Caregiving for Living Kidney Donors

H. Maple, N. Mamode.
The C1q-Binding Assays and Clinical Outcomes in Kidney Transplantation

P. Amico,¹ G. Hönger,¹ H. Hopfer,² R. Liwski.³
The Characteristics of Post-Operative Deep Vein Thrombosis in Kidney Transplant Recipients – Difference from Other Type of Surgery

J. Kim,¹ I. Moon,¹ M.-H. Kim,¹ K. Park,² S. Ahn,³ S. Park,⁴ S.-D. Kim,⁵ S. Kim.⁶
The Clinical Outcome of Plasma Cell-Rich Rejection of Kidney Allograft

J. Hasegawa,¹ K. Honda,² S. Wakai,¹ H. Shirakawa,³ M. Okumi,³ K. Omoto,³ H. Ishida,³ K. Tanabe.³
The Correlation Between Donor Specific Antibodies and Heart Transplant Rejection

R. Bedard,¹ P. Jindra,² M. Manson,¹ M. Moaddab,¹ H. Mallidi,³ W. Etheridge,¹ A. Civitello,³ R. Kerman.²
The Decreasing Rates of Organ Donation in Trauma Patients: An Analysis of the United Network for Organ Sharing Database

H. Aziz, T. Jie.
The Design and Implementation of a Genome-Wide Genotyping Array Tailored for Transplantation

B. Keating,¹ A. Israni,² Y. Li,¹ M. Holmes,¹ K. Birdwell,³ F. Asselbergs,⁴ A. Shaked.¹
The Differential Effect of HLA-DQ Mismatching on Renal Allograft Survival in Zero HLA-A,B,DR Mismatched Deceased Donor Transplants

M. Casey,¹ X. Wen,¹ S. Rehman,¹ A. Santos,¹ S. Goldstein,¹ K. Andreoni,¹ B. Kaplan,² K. Womer.¹
The Donor Risk Index Does Not Accurately Classify Patients With or Without Graft Failure

E. Franco,¹ T. Athanasios,² N. Kemmer,³ L. Leone,¹ A. Alsina,¹ B. Djulbegovic.²
The Economic Impact of Nonimmune Complications in Contemporary Kidney Transplantation

K. Lentine,¹ M. Schnitzler,¹ D. Axelrod,² D. Segev,³ D. Brennan,⁴ J. Tuttle-Newhall,¹ H. Xiao,¹ L. Kucirka,³ V. Dharnidharka.⁴
The Effect of Changing Candidate Demographics on Living Donor Kidney Transplant Rates

G. Vranic, A. Nishio Lucar, D. Keith.
The Effect of Compatibility of ABO Blood Type Antigens on Graft Survival of Intestinal Transplants

J. Cai,¹ A. Qing,² G. Wu,³ M. Everly,¹ P. Terasaki.¹
The Effect of Influenza Vaccination on Hospital Admission in Solid Organ Transplant Recipients

J. Rago, M. Hurtik, S. Todd, A. Mehta, G. Lyon III.
The Effect of Preformed and De Novo Donor-Specific Antibodies (DSA) in Acute Rejection (AR) After Liver Transplantation (LTX)

M. Koch,¹ M. Runnebaum,¹ M. Goebel,² H. Thude,¹ M. Sterneck,¹ M. Marget,² B. Nashan.¹
The Effect of Rituximab Therapy on Regulatory B Cell and Prevention of Chronic Antibody Mediated Rejection in Kidney Transplantation Recipients

M. Ikemiyagi, R. Ishii, S. Miyairi, T. Hirai, K. Omoto, K. Tanabe.
The Effect of Systemic Catecholamine Application On the Microcirculation in Liver Procurement

M. Strempel,¹ M. Kaths,¹ H. Lang,¹ G. Otto,¹ V. Weyer,² O. Kempski,³ A. Heimann,³ A. Schad,⁴ D. Foltys.¹
The Effects of Change in Body Mass Index on Morbidity and Mortality After Liver Transplantation

B. Kashat,² A. Prushani,¹ S. Jafri.¹
The Effects of Dialysis Vintage and Hypertensive Renal Failure on Colonoscopy Findings During Kidney Transplant Evaluation

Y. Zheng,¹ K. Chaung,¹ P. Park,¹ J. Augustine,² N. Sarabu,² J. Schulak,² E. Sanchez,² V. Humphreville,² J. Ammori,² K. Woodside.²
The Effects of Donor Specific Anti- Human Leukocyte Antigen Antibodies Late After Heart Transplantation

M. Kittleson, J. Patel, F. Liou, S. Siddiqui, A. Fong, M. Johnson, D. Chang, L. Czer, F. Esmailian, N. Reinsmoen, J. Kobashigawa.
The Effects of High-Risk Donors and Recipients on Scientific Registry of Transplant Recipients Program-Specific Outcomes

J. Snyder,¹ N. Salkowski,¹ D. Zaun,¹ J. Schold,² A. Israni,¹ B. Kasiske.¹
The Effects of Periostin on Renal Fibrosis After Ischemia-Reperfusion Injury Via p38 MAPK Pathway

J. An,^1,2 S. Yang,³ J. Hwang,⁴ J. Kim,¹ S. Kim,^2,5 C. Lim,^1,2 Y. Oh,^1,2 Y. Kim,² J. Lee.^1,2
The Effects of Various Cardiac Preservation Solutions on Survival After Heart Transplantation

C. Evans, K. Rajagopal, P. Sanchez, S. Rahimpour, F. Cheema, R. Pierson III, B. Griffith, S. Pham.
The Epidemiology of Surgical Site Infections Among Pediatric Liver Transplant Recipients

D. Banach,¹ A. Munoz-Abraham,² L. Dembry,¹ M. Rodriguez-Davalos.²
The Explore Transplant Program in GA: Is Historical Access to Transplantation Associated With Kidney Transplant Knowledge and Preparedness to Educate ERSD Patients?

J. Gander,¹ C. Isenhour,¹ L. McPherson,¹ M. Basu,¹ B. Tao,¹ K. Smtih,¹ S. Pastan,¹ A. Waterman,² R. Patzer.¹
The Extended Toronto Criteria for Transplantation for Hepatocellular Carcinoma. A Validation Study

G. Sapisochin, N. Goldaracena, J. Laurence, M. Dib, A. Barbas, A. Ghanekar, L. Lilly, E. Renner, M. Selzner, M. Cattral, I. McGilvray, D. Grant, P. Greig.
The Feasibility of Utilising DCD Kidneys for Paediatric Recipients: Early Outcomes

Z. Ahmed,¹ R. Batra,¹ S. Marks,³ H. Jones,⁴ N. Mamode.¹
The Forgotten Cell: Renal Fibroblasts Are Activated By Anti-MHC Class I Antibody

J. Chen, A. Zmijewska, R. Mannon.
The Gut Microbiota Regulates Murine Cardiac Transplant Outcome

C. Brinkman,¹ L. Hittle,¹ E. Mongodin,¹ W. Fricke,² J. Bromberg.¹
The Higher MFI of De Novo Donor-Specific Anti-HLA Antibodies Is Correlated With Graft Fibrosis Progression in Living Donor Liver Transplantation

Y. Fukasaku,¹ R. Goto,¹ S. Emoto,¹ N. Kawamura,¹ Y. Koshizuka,¹ T. Takahashi,¹ M. Ota,³ T. Aoyagi,¹ K. Yamashita,² A. Taketomi,¹ T. Shimamura.³
The Immunogenic Perlecan Fragment LG3 Is Released Through Apoptotic Extracellular Vesicles Downstream of Caspase-3 Activation

D. Beillevaire,¹ J. Turgeon,¹ D. Gingras,² é. Boilard,³ M. Dieudé,¹ M.-J. Hébert.¹
The Immunosuppressive Effect of CTLA4Ig Monotherapy Depends On the Presence of Tregs Only at Suboptimally Low Doses

C. Schwarz,¹ L. Unger,¹ B. Mahr,¹ K. Aumayr,² N. Pilat,¹ K. Hock,¹ A. Farkas,¹ I. Kristo,¹ T. Wekerle.¹
The Immunosuppressive Effects of Erythropoietin Do Not Confer Lower Rates of Acute Rejection in Post Kidney Transplant Recipients Receiving Darbepoetin

B. Fischbach,¹ S. Gonzalez,¹ A. Yango,¹ A. Chandrakantan,² A. Rajagopal,² K. Rice,² L. Melton,² Y. Barri,² M. Saim,² N. Onaca,¹ R. Ruiz,¹ M. Levy,¹ G. Klintmalm.²
The Impact of a Desensitization Protocol Using Plasmapheresis and Intravenous Immunoglobulin On Graft Outcome in Kidney Recipients With Donor Specific Anti-HLA Antibodies

J. Junqueira, T. Leite, A. Junqueira, R. Esmeraldo.
The Impact of Acute Rejection on Liver Transplant Survival in the New Millennium

J. Levitsky,¹ S. Forney,² B. Gillespie,³ R. Merion,^2,3 A. Lok,³ G. Levy,⁴ L. Kulik,¹ M. Abecassis,¹ A. Shaked.⁵
The Impact of Administrating Everolimus Before Cytomegalovirus Infection to Prevent CMV Recurrence in Heart Transplant Recipients

M. Ishida, K. Toda, T. Nakamura, S. Miyagawa, Y. Yoshikawa, S. Fukushima, S. Saito, D. Yoshioka, K. Kubota, T. Ueno, T. Kuratani, Y. Sawa.
The Impact of Alemtuzumab and Basiliximab Induction On Patient and Graft Survival in Single Lung Transplant Recipients

Y. Furuya,¹ S. Jayarajan,² S. Taghavi,² V. Ambur,² F. Cordova,³ N. Patel,³ Y. Toyoda.⁴
The Impact of Baseline and Follow-Up Social Adaptability Index Scores on Outcomes in Kidney Transplantation

D. Taber, M. Hamedi, M. Gebregziabher, T. Srinivas, K. Chavin, L. Egede, P. Baliga.
The Impact of CDC High Risk Donors on Patient and Graft Survival After Liver Transplantation

D. Moonka, A. Yoshida, A. Taylor.
The Impact of Center Size on Outcome of Pancreas Transplants

A. Gruessner,¹ R. Gruessner.²
The Impact of Center Volume on Simultaneous Kidney-Pancreas Transplantation Outcomes

A. Malone,¹ D. Brennan,¹ J. Wellen,² T. Alhamad.¹
The Impact of Critical Illness and Pre-Transplant Hospitalization on Cost of Liver Transplantation

S. Knechtle, L. Brummett, S. Perez.
The Impact of Cytokine Release Caused By Induction Immunosupression On Nitric Oxide in Renal transplantation

R. Johns,^1,2 M. Laftsidis,² E. Burrows,² F. Edwards,² E. Ablorsu,² P. James,¹ A. Phillips,^1,2 A. Asderakis.²
The Impact of Delayed Graft Function (DGF) and Acute Rejection (AR) on the Decline in Allograft Function After Kidney Transplantation

J. Gill, J. Dong, C. Rose, J. Gill.
The Impact of Donor Alcohol Intake on Pancreatic Graft Survival

R. Motallebzadeh,¹ M. Drage,² J. Olsburgh,² C. Callaghan.²
The Impact of Donor and Recipient Weight Incompatibility on Outcomes in Renal Transplantation

L. Wong,¹ S. Moran,¹ A. Counihan,² P. Cunningham,² P. O'Kelly,¹ P. Conlon.¹
The Impact of Duration of Brain Death on Outcomes in Abdominal Organ Transplantation: Rush and Retrieve or Rather Relax and Repair?

C. Boffa,¹ E. Curnow,² K. Martin,² R. Johnson,² R. Ploeg.¹
The Impact of FcγRIIA, FcγRIIIA and C1QA Genes Polymorphism On Infectious Complications Following Renal Transplantation

L. Das, Y. Tanaka, S. Verma, S. Shimizu, K. Ide, H. Ohdan.
The Impact of HCV on Post Transplant Biliary Strictures

N. Kemmer, E. Franco, A. Turner, C. Albers, J. Horkan, E. Parkinson, E. Cece, A. Alsina.
The Impact of High-Risk Lung Donors on the Survival of Lung Recipients With Interstitial Pulmonary Fibrosis

P. Sanchez,¹ M. Mulligan,¹ C. Evans,¹ I. Timofte,² J. Kim,² K. Rajagopal,¹ A. Iacono,² J. Gammie,¹ R. Pierson III,¹ B. Griffith,¹ S. Pham.¹
The Impact of Hypertension, Chronic Pain, and Fatigue on Long-Term Quality of Life After Living Kidney Donation

T. Schachtner,^1,2 P. Reinke.^1,2
The Impact of Ischemia/Reperfusion Injury On Liver Allografts from Deceased After Cardiac Death Versus Deceased After Brain Death Donors

B. Sayed, J. Xu, A. Casas-Ferreira, P. Srinivasan, N. Heaton, Y. Ma, C. Legido-Quigley, S. Fuggle, W. Jassem.
The Impact of Metabolic Syndrome and Prevalent Liver Disease on Living Donor Liver Transplantation: A Pressing Need to Expand the Pool

W. Al-hamoudi,^1,2 F. Abaalkhail,² A. Bendahmash,¹ N. Allam,² N. Almasri,² H. Al-Bahili,² M. Al-Sebayel,² D. Broering,² H. Elsiesy.²
The Impact of Microcirculation Inflammation in Predicting Treatment Response for Late Onset Antibody Mediated Rejection

J. Lee,¹ J. Lee,¹ B. Lim,² B. Kim,³ M. Ju,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ H. Jeong,² K. Park,⁴ K. Huh.¹
The Impact of MYH9 Polymorphic Variant rs5756168 on Kidney Allograft Function

J. Pazik,¹ M. Oldak,² Z. Lewandowski,³ D. Ozieblo,⁴ K. Michalska,⁵ E. Sitarek,¹ A. Sadowska,¹ M. Nowaczyk,⁵ T. Grochowiecki,⁶ J. Malejczyk,⁴ M. Durlik.¹
The Impact of Perioperative Bleeding on Long-Term Outcomes of Mechanical Circulatory Support

K. Lietz,¹ M. Mooney,¹ I. El Lakkis,² C. Derber,² U. Kelly,² C. Wilson,² A. Hoedt,¹ P. Bourassa,¹ B. Smith,¹ M. McGrath,¹ J. Herre.¹
The Impact of Preoperative Antimicrobial Prophylaxis on Device-Related Infections in Recipients of Long-Term Mechanical Circulatory Support (MCS)

I. El Lakkis,¹ K. Lietz,² C. Derber,¹ U. Kelly,¹ C. Wilson,¹ A. Hoedt,² P. Bourasssa,² B. Smith,² M. McGrath,² J. Herre,² M. Mooney.¹
The Impact of the Arterial Reconstructions On the Living Donor Kidney Graft

T. Hiramitsu, K. Futamura, M. Okada, K. Ito, M. Tsujita, N. Goto, S. Narumi, Y. Watarai.
The Impact of the New Antivirals Sofosfuvir/Ledipasvir on Liver Transplantation for Hepatitis C Cirrhosis

S. Munoz,¹ D. Reich,² K. Rothstein.¹
The Impact of Therapy On the Inflammatory Infiltrate in Renal Allografts With Acute and Chronic Antibody Mediated Rejection

W. Mulley,^1,2 D. Nikolic-Paterson,^1,2 A. Longano,³ Y. Han,¹ F. Ma,¹ J. Kanellis,^1,2 S. Ramessur.^1,2
The Impact of Ureteral Complications After Pediatric Renal Transplantation

J. Finkelstein,¹ J. Pak,¹ N. Jain,¹ P. Sandoval,² S. Alam.¹
The Influence of Immunosuppressive Drugs On the Epithelial Microenvironment in Solid Organ Transplantation – Identification of Biomarker Candidates for Rejection Vs. Tolerance

A. Akhdar,¹ B. Mueller,² C. Neudoerfl,¹ F. Lehner,³ M. Stevanovic-Meyer,¹ K. Daemen,¹ J. Keil,¹ H. Haller,⁴ C. Blume,^4,5 C. Falk.^1,6
The Liver X Receptor Alpha (LXRα) Knockout Protect Liver Against Ischemia-Reperfusin Injury in Mice

T. Lu,¹ D. Li,¹ J. Zhang,¹ M. Zhang,¹ X. Cui,¹ H. Dai,¹ X. Liu,² Q. Xia.¹
The Losing Trifecta: Age ≥70, Deceased Donor Transplant, and Delayed Graft Function

R. Crew, H. Fernandez, S. Mohan, G. Dube, L. Ratner, R. Sandoval, S. Patel.
The Molecular Landscape of Atrophy-Fibrosis in Human Kidney Transplants: The Dominant Role of Acute Parenchymal Injury

J. Venner, P. Halloran.
The Natural History of Kidney Graft Cortical Microcirculation Determined by Real-Time Contrast-Enhanced Sonography (RT-CES)

C. Jiménez,¹ M. López,¹ A. Ros,¹ A. Aguilar,¹ D. Menendez,¹ B. Rivas,¹ M. Santana,¹ R. Madero,² R. Selgas.¹
The Negative Impact of Hepatitis C Infection (HCV+) On Orthotopic Liver Transplantation (OLT) for Hepatocellular Carcinoma (HCC)

A. Daoud,^1,3 L. Teeter,² E. Graviss,² S. Burroughs,¹ A. Gaber.¹
The Occurrence of v- Lesions Is Not Associated With Decreased Graft Survival

P. Halloran, I. Salazar, M. Lopez, J. Chang.
The Onset of Post-Transplant Malignancies Is Related to a Change in Gene Expression Profiles in Peripheral Blood Mononuclear Cells

G. Stallone,¹ R. Federica,¹ P. Pontrelli,² M. Accetturo,² A. Oranger,² M. Gigante,² G. Castellano,² A. Schena,² M. Fiorentino,² B. Infante,¹ L. Gesualdo,² G. Grandaliano.¹
The Outcome of Carbapenemase-Producing Enterobacteriaceae (CPE) Infection in Adult Solid Organ Transplant Population at a University Teaching Hospital

H. Sharma, A. El-Bakry, V. Venkat, S. Papachristos, P. Otilla, R. Dhanda, B. Forgacs, A. Tavakoli, R. Pararajasingam.
The Outcomes of Second Transplantation in Recurrent IgA Nephropathy

C. Baek,¹ H. Kim,¹ W. Yang,¹ W. Huh,² Y. Kim,³ J. Yang,⁴ D. Han,⁵ S.-K. Park.¹
The Penalty Faced By Native Americans in Kidney Transplantation: Decreased Access and Reduced Long-Term Survival

S. Stith,¹ F. Barrantes,² K. Piorkowski.¹
The Potential of E-Health to Improve Adherence: Exploring the Patients' View

D. Slaats,¹ M. Tielen,¹ M. Laging,¹ T. van Gelder,² W. Weimar,¹ E. Massey.¹
The Potential Use of the Plasma Biomarker CXCL9 (MIG), Interleukin 2 Receptor alpha (IL2Rα) and SCGF-b as Predictors of Renal Graft Rejection

C. Blume,¹ S. Michael,² N. Christine,³ H. Hermann,⁴ F. Christine.³
The Predictive Value of the Proliferation Marker Ki-67 in Patients With Fulminant Hepatic Failure

A. Shah,¹ U. Joneja,² D. Walls,¹ J. Farber.²
The Preservation Technique Modulates the Immunological Milieu in Lung Transplantation and Affects the Pro-/ Anti-Inflammatory Balance

M. Seyda,¹ B. Wiegmann,³ B. Mueller,² C. Neudoerfl,¹ A. Akhdar,¹ K. Daemen,¹ A. Haverich,^3,4 G. Warnecke,^3,4 C. Falk.^3,5
The Product of Donor Age and Preoperative MELD, D-MELD, Predicts Surgical Outcomes After LDLT, When Using Small Graft

A. Tanemura, S. Mizuno, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.
The Relationship Between Age and Morbidity During the First Year Following Renal Transplantation in Patients Receiving Alemtuzumab Induction

S. LeCorchick, N. Wilson, C. Truscott, D. Shaffer, S. Karp, B. Concepcion, M. Stanley, I. Feurer, S. Bala.
The Role of an Intragraft Vascularized Bone Marrow Niche in Establishing Mixed Chimerism and Allograft Acceptance

M. Fryer, B. Oh, G. Furtmüller, G. Raimondi, G. Brandacher.
The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review

M. AlDabbagh,^1,2 M. Gitman,³ D. Kumar, A. Humar, C. Rotstein, S. Husain.^1,3
The Role of Hemodialysis Social Networks in Transplantation: Five Year Follow Up of an Urban Hemodialysis Cohort

A. Pai, A. Gillespie.
The Role of Immunosuppression on Cardiac Functions of Kidney Transplant Recipients

U. Cakir, O. Cavdaroglu, T. Erturk, E. Gurluler, A. Gurkan, I. Berber.
The Role of Inflammasome Components in Renal Tubular Epithelial Cell Injury

S. Kasimsetty, A. Shigeoka, D. McKay.
The Role of Quantitative Assay of Urinary Decoy Cells as a Screening and Follow-Up Tool in Renal Transplant Recipients With Polyomavirus BK Infection

G. Huang, J. Qiu, C.-X. Wang, J.-G. Fei, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.
The Role of Skin-Specific Immunobiology and Major Histocompatibility Complex Sharing in Vascularized Composite Allograft Tolerance

D. Leonard, K. Shanmugarajah, H. Powell, A. Albritton, C. Mallard, D. Sachs, C. Cetrulo, Jr., J. Kurtz.
The Role of the Incretin Effect After Pancreas Transplantation

S. Mittal,¹ R. Franklin,¹ E. Sharples,¹ F. Knop,² J. Holst,² S. Gough,¹ P. Friend.¹
The Selection Process for Total Artificial Heart

F. Arabia, L. Czer, M. Kittleson, E. Passano, F. Liou, J. Yabuno, H. Henry, D. Chang, F. Esmailian, J. Kobashigawa, J. Moriguchi.
The Significant Association Between the Functional Polymorphism (Rs3761548) of Foxp3 Gene and the Severity of Acute Cellular Rejection in Liver Transplantation

S. Verma, Y. Tanaka, S. Shimizu, L. Das, H. Ohdan.
The Spleen Is the Primary Site for Breg Induction and Is Required for Anti-TIM-1 Mediated Tolerance

K. Mohib, Q. Ding, A. Cherukuri, D. Rothstein.
The Synergistic Effect of Class II HLA Epitope-Mismatch and Non-Adherence on Acute Rejection and Graft Survival

C. Wiebe,^1,2 T. Nevins,³ W. Robiner,^3,4 W. Thomas,⁵ A. Matas,⁶ P. Nickerson.^1,2,8
The Use of a Nurse Practitioner Led Transitional Diabetes Clinic Following Transplantation

N. Cardinez, P. Segal, S. Trohonel.
The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant

J. Benken,¹ S. Akkina,² E. Benedetti.³
The use of Donation After Cardiac Death Liver Allografts does not increase Recurrence of Hepatocellular Carcinoma

K. Croome, D. Lee, J. Burns, J. Nguyen, D. Perry, D. Harnois, C. Taner.
The Use of Eculizumab to Treat the Highly Sensitized Patient Awaiting Heart Transplant

J. Patel, D. Dilibero, M. Kittleson, S. Sana, F. Liou, D. Chang, A. Hage, L. Czer, A. Trento, N. Reinsmoen, J. Kobashigawa.
The Use of Inhaled Tobramycin in Pediatric Transplant Patients Without Cystic Fibrosis

C. Pfeifer,¹ M. Keck.²
The Use of Systems Biology to Identify Mitochondrial Dysfunction and Metabolic Dysregulation as Targets for Intervention in the Brain Dead Organ Donor

M. Akhtar, L. Lo Faro, R. Robelledo, M. Kaisar, H. Huang, H. Leuvenink, P. Friend, S. Fuggle, C. Pugh, R. Ploeg.
The Utility of Non-Invasive Intra Abdominal Pressure Monitoring After Pediatric Abdominal Organ Transplantation

E. Harkin,¹ M. McLeod,¹ K. Khan,² A. Natarajan.³
The Value of Perfusion Fluid Culture Analysis in Deceased Donor Renal Transplants. 5 Years Single Centre Experience

A. Al Midani, S. Collier, K. Welman, B. Fernando, B. Lindsey, C. Forman, N. Banga.
The Value of Surveillance Testing for De Novo Donor Specific Antibodies Following Renal Transplantation

O. Pankewycz,¹ M. Laftavi,² M. Said,² K. Chapin,² L. Feng.²
Third Party Mesenchymal Stromal Cell Infusion in Kidney Transplant Recipient: 6-Month Safety Interim Analysis

L. Weekers,¹ P. Erpicum,¹ O. Detry,³ C. Lechanteur,² E. Baudoux,² F. Jouret,¹ Y. Beguin.²
Three Year Outcomes of Renal Allograft Transplants in African American Recipients Receiving Alemtuzumab for Induction Immunosuppression

P. Vaitla, H. Bohorquez, A. Cohen, A. Cruz, U. Patel, S. Anders, C.-S. Catherine, A. Moiz, S. Guisti, I. Carmody, G. Loss, D. Bruce, T. Reichman, J. Garces.
Thymic Transplantation to Determine Mechanisms of Thymic Involution: Insulin-Like Growth Factor 1 Receptor and Forkhead Box Protein N1 in the Thymus Play a Role in Maintaining the Juvenile Thymus

K. Yamada, M. Tasaki, M. Sekijima, A. Kawai, V. Villani, T. Tanabe, I. Hanekamp, A. Shimizu, D. Sachs.
Thymoglobulin Administration During Multi-Visceral and Isolated Small Bowel Procurement Does Not Adversely Affect the Survival of Harvested Organs

G. Jain, T. Burnett, J. Preheim, L. Vargas, W. Grant, A. Langnas, D. Mercer, G. Jain.
Thymoglobulin Dosing Efficacy: The Role of ALC on Infection and Rejection

H. Sarumi, C. Borscheid, G. Sieger, B. Fast, S. Hogan, K. Vassar, T. Pruett.
Thymoglobulin Versus IL2RA: Three Year Results of a Randomized Controlled Trial

N. Pilch, H. Meadows, D. Taber, J. Fleming, C. Mardis, S. Nadig, J. McGillicuddy, T. Srinivas, C. Bratton, P. Baliga, K. Chavin.
TIM-4 Identifies IL-17 Expressing Pro-Inflammatory Be-17 Cells That Promote Allograft Rejection

Q. Ding, K. Mohib, D. Rothstein.
Timing of Pregnancy and Risk of Kidney Allograft Failure

C. Rose, O. Johnston, A. Mehrotra, C. Kennedy, T. Myint, E. Hendren, J. Gill, J. Gill.
Tissue Distribution, Preparation and Phenotype Characteristics of Stem Cells Originated from the Organs of Deceased Human Individuals

A. Klimczak,¹ T. Jurek,² M. Czuba,² U. Kozlowska,¹ M. Rorat,² K. Wrzeszcz.¹
Tissue Engineering Human Kidneys for Costimulation Blockade

L. Brasile,¹ N. Henry,¹ A. Meyer,¹ B. Stubenitsky.²
Tobacco Use Is a Significant Risk Factor for Post-Transplant Biliary Complications

D. Dulaney, M. Dokus, M. Orloff, R. Kashyap.
Tolerance to Graft A-Antigens Following ABO-Incompatible Heart Transplantation (HTx) in a Blood Group A-Transgenic Mouse Model

B. Motyka,¹ K. Labonte,¹ F. Rahman,¹ J. Pearcey,¹ K. Tao,¹ M. Mengel,¹ B. Sis,¹ P. Cowan,² L. West.¹
Tolerant Kidney Transplant Patients Display B Cells With Regulatory Properties

S. Brouard,^1,2 M. Chesneau,^1,3 L. Michel,^1,2,3 E. Dugast,^1,3 A. Chenouard,^1,3 A. Pallier,¹ D. Baron,^1,3 J. Durand,^1,3 F. Braza,^1,3 P. Guerif,² D.-A. Laplaud,^1,2,3 J.-P. Soulillou,^1,2,3 M. Giral,^1,2,3 N. Degauque,^1,3 E. Chiffoleau,^1,3 S. Brouard.^1,2
Toll-Like Receptor 4-Signaling Abrogates Inhibitory Effect of Calcineurin Inhibitor on B-Cells Responding to Blood Group A-Antigens

H. Sakai, Y. Tanaka, H. Ohdan.
Toxicity Driven Conversion to Belatacept in Kidney Transplant Recipients

E. Cohen, W. Asch, R. Formica, E. Tichy.
Toxoplasmosis Post-Kidney Or Liver Transplantation: A Serie of Cases

L. Pierrotti, R. Salles, M. Rytholz, L. Azevedo, A. Song, L. D'Albuquerque, E. David-Neto, W. Nahas, E. Abdala.
Tracking T Cell Fate After Antithymocyte Globulin (ATG) Immunotherapy in Infant Heart Transplant (HTx) Patients

S.-I. Wang,^1,2 I. Larsen,^1,2 S. Urschel,^1,2 R. Chinnock,³ J. Rusch,³ L. West.^1,2
Trajectory of Measured GFR Decades After Kidney Donation: Hyperfiltration Never Seems to End!

H. Ibrahim, D. Berglund, R. Foley, A. Matas.
Transient Lymphopenia Breaks Costimulatory Blockade-Based Transplant Tolerance and Initiates Allograft Rejection

S. Iida,¹ T. Suzuki,² K. Tanabe,¹ A. Valujskikh,³ R. Fairchild,³ R. Abe.²
Transplant Center Quality Assessment: Correlation Between Early Graft Outcomes and Patient-Centered Assessments of Hospital Care

A. Mathur,¹ A. Chakrabarti,² K. Sheetz,² N. Katariya,¹ A. Singer,¹ W. Hewitt,¹ K. Reddy,¹ A. Moss.¹
Transplant Glomerulitis in Allograft Kidneys Is Correlated With Antibody-Mediated Rejection

W. Xu, T. Deng.
Transplant Glomerulopathy in a Novel Model of Chronic Antibody Mediated Rejection Is Associated With DSA and Glomerular IgM

S. Panzer,¹ S. Reese,¹ N. Wilson Schlei,¹ W. Zhong,² A. Djamali.¹
Transplantation of Kidneys from Donors With Acute Renal Failure: Five-Year Results from Double Center Experience

C. Ramirez,^1,2 A. Safra,¹ A. Shah,^1,2 C. Doria,¹ W. Maley,¹ A. Frank,¹ C. Gorn,¹ L. Lerner.²
Transplantation of Neonatal En-Bloc Kidneys: Do They Grow and Are They Subject to Hyperfiltration Injury?

J. Woloszyn, C. Santhanakrishnan, C. Troppmann, A. DeMattos, B. Gallay, J. McVicar, J. Sageshima, R. Perez.
Transplanting Pediatric Livers Into Adult Recipients Is Associated With Increased Rejection and Decreased Survival

V. Fleetwood, J. Harris, M. Hertl, E. Chan.
Transport Perfusion Fluid Analysis from Deceased Donor Kidney Transplants (DD KT) and Pancreas Transplants (SPK; PAK; PTA)

C. Taylor, Y. Tabbakh, C. van Nispen tot Pannerden, D. Yershov, F. Calder, C. Callaghan, M. Drage, N. Karydis, N. Kessaris, I. Loukopoulos, N. Mamode, J. Olsburgh.
Transversal Observational Study On Recurrent and Late Urinary Tract Infections (UTIs) in Renal Transplantation (tx)

G. Castellano,¹ M. Fiorentino,¹ M. Martino,¹ M. Rossini,¹ A. Schena,¹ C. Manno,¹ G. Grandaliano,² P. Ditonno,³ M. Battaglia,³ L. Gesualdo.¹
Treatment of Hepatitis C Virus in Kidney Transplant Recipients With Direct Acting Anti-Viral Agents: Early Results in 12 Cases

A. Sharfuddin,¹ T. Taber,¹ M. Mujtaba,¹ M. Yaqub,¹ D. Mishler,¹ P. Kwo,² R. Vuppalanchi.²
Treatment of Hypertrophic Osteoarthropathy in an Intestinal Transplant Patient After Acute Cellular Rejection

M. Keck.
Treatment of Subclinical Rejection Identified On Surveillance Biopsy May Prevent the Development of Chronic Alloimmune Injury

M. Willicombe, C. Roufosse, J. Galliford, A. McLean, D. Taube.
Treatment Patterns, Healthcare Resource Utilization, and Costs in Kidney Transplant Recipients Using a Fixed Source Regimen of Tacrolimus Vs. a Variable Source Regimen

E. Lee,¹ S. Bunniran,² P. Kamble,² B. Suehs,² B. Franks,¹ J. Schwartz,¹ C. Anderson,³ G. Thal,¹ J. Spalding.¹
Treatment With Everolimus and Reduced-Exposure Cyclosporine Is Efficacious in De Novo Renal Transplant Recipients at Increased Risk for Efficacy Failure: Post-Hoc Analysis from the A2309 Study

M. Carmellini,¹ V. Garcia,¹ Z. Wong,² M. Vergara,² C. Escrig,² G. Russ.¹
Trends in Transplant Patient Safety Situation Reporting

T. Daly,¹ H. Neil,² D. Stewart,² S. Tlusty,² A. Harper,² D. Marshman,³ M. Green.⁴
Type III Phosphodiesterase (PDE3) Inhibitor Improves Survival Rate After Ischemia Reperfusion Injury of the Liver in Rats

T. Fujii,¹ H. Obara,² N. Fujimura,² K. Matsubara,² Y. Kitagawa.²
Type of Caregiver and Outcome After Mechanical Circulatory Support Placement

H. Henry, F. Arabia, M. Kittleson, L. Czer, E. Passano, J. Yabuno, S. Siddiqui, E. Antifantis, D. Chang, J. Kobashigawa.